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Abstract 
The XA~ system, a sodium-dependent, acidic amino-acid transport system has been implicated in the transport of L-aspartate and 
L-glutamate across monolayers of human Caco-2 cells, an in vitro model of intestinal absorption. This system, which shares many 
properties with the L-glutamate carder present in the human jejunum, is highly saturable (> 95% at 50 /zM), vectorial (apical-to-baso- 
lateral >> basolateral-to-apical) nd sodium-, pH- and temperature-dependent. L-Aspartate was also transported against a 10-fold reverse 
concentration gradient. These data are consistent with a major (saturable) carrier-mediated pathway superimposed onto a minor 
non-saturable (diffusional) pathway. The carrier has an absolute sodium-dependence andthe Michaelis constants for the sodium-depen- 
dent transport component (K  m) for L-aspartate and L-glutamate were 56 + 3 /zM and 65 + 6 /zM, respectively. Cross-inhibition studies 
showed that strong interaction with the carder was limited to close analogues of the natural substrates. Potent inhibitors included 
L-aspartate, D-aspartate (K i, 70 /xM), L-glutamate (K i, 180 pM) and threo-fl-hydroxy-DL-aspartate (Ki, 55 p.M), while partial inhibitors 
included a-methyl-DL-aspartate, D-glutamate, L-asparagine, L-proline and L-alanine. Replacement of the side-chain -CO0- group 
(aspartate) with -SO 3 (L-cysteate, K i, 65 /~M) or -(H)P(O)O- (DL-3-(hydroxyphosphoryl)alanine, K i, 60 p~M) maintained strong 
interaction with the carrier while -As(O)(OH)O- (DL-3-arsonoalanine, Ki, 1100 /xM) and -P(O)(OH)O- (DL-3-phosphonoalanine, K i
3270/~M) were much more weakly bound, with the larger, but probably less ionised, arsono analogue being more tightly bound than the 
phosphono compound. The corresponding analogues of glutamate (homologous extension of the methylene chain) showed negligible 
interaction. We conclude that Caco-2 monolayers are a relevant experimental model for the study of the transport of acidic amino acids 
and their analogues in man. 
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1. Introduction 
Several carrier systems have been implicated in the 
uptake of acidic amino acids from the gastrointestinal tract 
[1,2]. One of these, the XA~ sodium-dependent anionic 
transport system, which serves both L-aspartate and L- 
glutamate, is apparently ubiquitous. Whilst XA~-carriers 
from a variety of tissues and species share many proper- 
ties, subtle mechanistic distinctions uggest hese carriers 
represent a family of closely related, but not identical, 
transporters. The existence of a human intestinal carder for 
acidic amino acids was deduced from the clinical observa- 
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tion that children with raised concentrations of dicar- 
boxylic amino acids in their urine had deficient intestinal 
absorption of L-aspartate and L-glutamate [3]. Secondly, 
human jejunal brush border membrane vesicles (BBMV) 
accumulate acidic amino acids in a concentration-, pH- 
and sodium-dependent manner [4,5]. However, the scarcity 
of human tissue, and its rapid loss of integrity upon 
excision, [6] has restricted our knowledge of the acidic 
amino-acid transporter in humans. 
Caco-2 cells [7,8] are derived from a human colonic 
adenocarcinoma and show morphological and physio- 
logical differentiation characteristic of enterocytes under 
standard culture conditions; monolayers, when cultured on 
permeable supports, are a transport model of the adult 
human small intestinal epithelium [9-11 ]. Carrier-mediated 
uptake and transport of nutrient molecules by Caco-2 cells 
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Fig. 1. Structures of acidic amino acids (1,6) and analogues (2-5,7,8) used in this study. [L- and ~Aspartic acid (1), L- and D-glutamic acid (6), 
DL-3-(hydroxyphosphoryl)alanine (2), OL-3-phosphonoalanine (3), L-cysteic acid (4), DL-3-arsonoalanine (5), DL-2-amino-4-phosphonobutyric acid(7) and 
DL-2-amino-4-arsonobutyric acid (8)]. 
has been investigated and there is a similarity with many 
transporters present in the small intestine. Transported 
ligands include amino acids [9,12,13], bile acids [10,11], 
cephalexin [14], folic acid 1115], hexoses [16,17], inorganic 
phosphate [18] and vitamin B12 [19]. Additionally, a good 
correlation between the passive transport across Caco-2 
monolayers and their oral bioavailabilities in humans has 
been reported [20]. Since transport across Caco-2 monolay- 
ers may model transport in the human gastrointestinal 
epithelium, we report here such transport of L-aspartate 
and L-glutamate and the effect of related competitors (Fig. 
1) on this process. 
2. Materials and methods 
2.1. Materials 
L-[2,3-3H]Aspartate (25 Ci mmo1-1) and L-[U- 
]4C]aspartate (220.4 Ci mo1-1 ) were purchased from New 
England Nuclear (Dupont, Germany); L-[G-3H]glutamate 
(45 Ci mol-l) was obtained from Amersham, UK and 
were shown to be chromatographically homogeneous be- 
fore use. DL-3-Arsonoalanine was made [21] by a Strecker 
synthesis on arsonoacetaldehyde, rived from periodate 
oxidation of 2,3-dihydroxypropylarsonic a id; DL-2- 
aminoarsonobutyric and DL-2-aminophosphonobutyric 
acids were made [22,23] by treating diethylacetamidoma- 
lonate with dipropyl-2-chloroethylarsonate or diethyl-2- 
bromoethylphosphonate; DL-3-(hydroxyphosphoryl)alanine 
was synthesised [24] from 2 equivalents of ethyl trimethyl- 
silyl(diethoxymethyl)phosphonite and acetamidoacrylic 
acid by Dr S. Freeman, Aston University. Cycloheximide 
was purchased from the Aldrich chemical company. The 
Caco-2 cell line was confirmed mycoplasma-negative us- 
ing the Hoechst 33258 test [25]. Dulbecco's modified 
Eagle's medium (DMEM), foetal bovine serum (FBS), 
L-glutamine, non-essential mino acids (NEAA) and peni- 
cillin-streptomycin (10000 IU ml -~ and 10 mg ml -]) 
were supplied by Gibco (Paisley, Scotland, UK) Culture 
plastics were purchased from Sterilin (Hounslow, UK). 
Phosphate-buffered saline (PBS) tablets were from Oxoid 
(Basingstoke, UK). All other chemicals were of cell cul- 
ture grade or the highest purity available from Sigma 
(Poole, UK). 
2.2. Media 
Maintenance medium (M1): DMEM containing 10% 
v/v FBS, 1% v/v NEAA and 1% v/v glutamine; perme- 
able support medium (M2): maintenance medium (M1) 
containing 1% v/v penicillin and streptomycin; ion-con- 
trolled media (M3): this was used to investigate he cation- 
and anion-dependence of L-aspartate transport across 
Caco-2 monolayers. It comprised, 140 mM NaC1, 4 mM 
KH2PO 4, 5.2 mM K2HPO4, 1.2 mM MgSO4, 1.3 mM 
calcium gluconate, 0.01% Phenol red and 5 mM D-glucose 
(pH 7.4). Chloride-free M3-media were prepared by 
equimolar substitutions ofNaCI with sodium iodide (M3 I) 
sodium isethionate (M3ls t) or sodium thiocyanate (M3Ncs). 
Sodium-free M3-media were prepared by equimolar substi- 
tution of NaC1 with the chloride salts of choline (M3ch), 
lithium (M3Li), potassium (M3K), rubidium (M3Rb) or 
caesium (M3cs). Transport medium (M4): this was used 
for the majority of experiments on the transport of acidic 
amino acids and comprised Hanks' balanced salt solution 
(HBSS) containing 0.1% w/v BSA, 0.01% Phenol red, 5 
mM D-glucose and buffered with 14 mM N-(2-hydroxy- 
ethyl)piperazine-N'-(2-ethanesulfonic acid) (Hepes, pH 7.0, 
7.4 or 8.0) or 2-(N-morpholino)ethanesulfonic acid (Mes, 
pH 5.5, 6.0 or 6.5). M4-medium buffered to pH 7.4 was 
used unless pecified. A sodium-free version was prepared 
by equimolar substitution of NaCI with choline chloride 
(M4ch). 
2.3. Cell culture 
Caco-2 cells were cultured with maintenance medium in 
150 cm 2 plastic T-flasks; they were incubated at 37°C in a 
humidified atmosphere of 10% CO z in air and the medium 
was renewed every 48 h. Stock cultures were passaged 
(1:3) weekly by treatment with 0.25% w/v trypsin and 
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0.2% w/v  disodium ethylenediaminetetraacetate in phos- 
phate-buffered saline, pH 7.2 (PBS). [13,26] Cells were 
used for experiments between passages 95 and 117. For 
transport experiments, cells were cultured on 30 mm nitro- 
cellulose (Millicell HA, Millipore, Bedford, MA, USA) 
permeable supports. Post-confluent monolayers (2-3 d) 
were trypsinised and resuspended in permeable-support 
medium. The viable cell density was determined by 
haemocytometry using a Trypan blue exclusion test, then 
reduced to 5.0. l05 ceils ml-1 with additional permeable 
support medium. The permeable supports were conditioned 
with permeable support medium for 2 h before seeding 
with 4 ml of cell suspension (2.0.106 cells). Permeable- 
support medium (3 ml) was added to the basolateral 
chamber. The inserts were not disturbed for 72 h; there- 
after, the permeable support medium was replaced every 
48 h. To investigate the expression and polarity of L- 
aspartate transport with time in culture, experiments were 
initially performed at 7, 14, 21 and 28 d; thereafter, 
monolayers were used after 21 d. For uptake experiments, 
Caco-2 monolayers were cultured on plastic six-well cul- 
ture plates (Nunclon). Caco-2 monolayers (6 d) were ini- 
tially washed twice for 5 min with phosphate-buffered 
saline (PBS; 5 ml) (2 X 5 ml X 5 min) and finally (1 X 2 
ml X 15 min) with medium before the substrate in the 
medium was applied to their surface. After a 15 min 
incubation at 37°C, the donor solution was aspirated and 
the monolayers carefully rinsed (3 x 5 ml X 5 min) with 
ice-cold PBS stop-solution containing sodium azide 
(0.05%). Each Caco-2 monolayer was solubilised by shak- 
ing with 2 ml of 0.1% v /v  Triton X100 (TX100) in double 
distilled water; the mixture was added to l0 ml of Op- 
tiPhase Hisafe 3 (LKB) scintillation cocktail and the con- 
centration of radiolabel was determined using a Packard 
Tri-carb 200CA liquid scintillation analyser. 
2.4. Uptake experiments 
The monolayers received their final change of medium 
48 h before an uptake study. The medium was aspirated 
and the monolayers were twice washed with 5 ml PBS for 
5 min (2 X 5 ml X 5 min) and finally with incubation 
medium (1 × 2 ml X 15 min). The cells were pre-in- 
cubated with M4-medium, M4ch or M4-medium contain- 
ing ouabain (10-5000 /zM) for 45 min and the uptake of 
50 /zM L-[3H]aspartate (1.0 /zCi m1-1) in the appropriate 
medium, was measured at 37°C over a period of 20 min. 
Washing and incubation solutions were equilibrated to 
37°C for 1 h before use. At the end of the incubation 
period the medium was removed from each well and its 
3H-content determined by liquid scintillation counting. 
2.5. Transport experiments 
Permeable-support medium was aspirated from the api- 
cal (AP) and basolateral (BI) chambers and the monolayers 
were washed once for 15 min with 2 ml of incubation 
medium in each of the apical and basolateral compart- 
ments (1 X (2 ml Ap + 2 ml B1) X 15 min). The donor and 
receiver washing- and incubation-solutions were depen- 
dent on experimental requirements. The transport experi- 
ments were initiated by aspirating the washing-solutions 
and applying a donor-solution (2 ml) of transport medium 
(M4) containing 50/xM of L-[3H]aspartate (1.0/~Ci ml l ), 
L-[ 14 C]aspartate (0.25 /zCi ml- 1 ) or L-[ 3 H]glutamate (1.0 
/zCi ml -j ). The culture-insert and donor-solution were 
immediately transferred to a chamber containing 2.5 ml of 
receiver-solution. All washing-and transport-solutions 
were equilibrated to 37°C for 1 h before use. Apical-to- 
basolateral transport was followed by sequentially transfer- 
ring the culture-insert into a new receiver-chamber at 
defined time intervals. Solutions were added to 10 ml of 
OptiPhase Hisafe 3 (LKB) scintillation cocktail for quan- 
tification. After the final receiver-sample had been col- 
lected, monolayers were transferred toa cold-table (0-4°C) 
and the apical donor-solutions were collected and counted 
in a similar way. 
Transport in the reverse direction (i.e., basolaterai-to- 
apical) was also determined. The rate of radiochemical 
appearance in the apical chamber from a basolateral 
donor-solution was monitored with time. At defined time- 
intervals, the culture-insert was removed from the basolat- 
eral donor-solution and the entire apical receiver-solution 
collected then carefully replaced with fresh transport- 
medium and the culture-insert returned to the donor-solu- 
tion. After the final apical receiver-sample had been col- 
lected, monolayers were transferred toa cold table (0-4°C) 
and the basolateral donor-solutions collected and their 
radiochemical concentrations determined. The radiochemi- 
cal flux into the apical receiver-solution was determined at
each time; values were summed and expressed as cumula- 
tive flux with respect o time. 
The standard protocol for acidic amino acids was modi- 
fied to study transport mechanisms: acidic amino-acid 
transport was investigated over a range of apical substrate 
concentrations (50 /zM to 50 mM); apical pH values (5.5 
to 8.5); sodium-concentrations (0 to 140 mM; osmolarity 
was maintained by the addition of appropriate amounts of 
choline) and temperatures (4, 20 and 37°C). Inhibition of 
L-aspartate or L-glutamate (50 /zM) transport by a 20-fold 
excess of unlabelled analogues (1 mM) was used to exam- 
ine the substrate-specificity of the transporter for acidic 
amino acids. In addition, the influence of a 10-fold re- 
versed concentration gradient was studied. 
2.6. Competition and inhibition 
Inhibitors for the Na+/K+-ATPase (50 /xM ouabain), 
oxidative-phosphorylation (10 mM sodium azide + 50 mM 
2-deoxyglucose (DG); Nj+ 2-DG) or protein synthesis 
(500 /xM cycloheximide) on transport were investigated. 
Monolayers were pre-incubated for 45 min with M4- 
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medium alone (control) or with M4-medium containing the 
appropriate inhibitor before the apical-to-basolateral t ns- 
port of 50 /xM L-aspartate was measured over a period of 
60 min. For competition, the culture medium was removed 
by aspiration, the cells were washed [1 × (2 ml Ap + 2 ml 
BI)× 15 min] at 37°C with M4 medium and the L- 
[3H]aspartate or L-[3H]glutamate (50 /~M) alone (control) 
or in the presence of a twenty-fold excess of the competi- 
tor (1 mM) shown in Table 4 were added to the apical 
surface. Medium from the basolateral chamber was col- 
lected after 60 min, the flux of radiolabelled amino acid 
determined and the degree of inhibition calculated. 
2. 7. Identification of transported radiochemicals 
Samples were analysed for L-[3H]aspartate by ion-ex- 
change high-performance liquid chromatography. Proteins 
in the basolateral (receiver) sample (2.5 ml) were precipi- 
tated with 40% w/v  (aq) trichloroacetic a id (100/~l) and 
pelleted by centrifugation at 11 600 × g (MSE minifuge). 
The supernatant (20 /xl) was injected onto a cation ex- 
change column (Partisil SCX, 250 mm × 4.6 mm) and 
eluted with 0.01 M potassium phosphate buffer (pH 3.0) at 
a flow-rate of 1.5 ml rain -1. Effluent fractions were 
collected at 1 min intervals (Gilson, Model 204) and 
analysed for 3H-content lay liquid scintillation counting. 
An L-[3H]aspartate r ference sample in M4-medium was 
prepared then processed and analysed in an identical way. 
2.8. Calculation of the inhibition constant (K i) 
The inhibition constant (K i )  of competitors was esti- 
mated from the observed inhibition of carrier-mediated 
L-aspartate or L-glutamate transport using the ratio (r)  of 
the transport ate in the absence of an inhibitor to the value 
in the presence of an inhibitor (Eq. 1). 
K~[ I] 
Kg = ( r -  1)(K m + [S]) (1) 
K m is the Michaelis constant for sodium-dependent 
transport, and [S] and [I] ~re the concentrations of substrate 
and inhibitor, assuming that the compounds inhibit trans- 
port competitively [27,28]: 
3. Results 
Tritium in the non-TCA precipitable fraction of the 
basolateral receiver solution co-eluted with the reference 
L-[3H]aspartate sample (t R 4 min). Only 0.54 + 0.22% of 
the total 3H was TCA-precipitable and this was not signifi- 
cantly reduced by a 45 rain pre-incubation with 500 /xM 
cycloheximide (0.47 _+ 0.16%) to inhibit protein synthesis 
(Results not shown). Therefore, L-aspartate was not appre- 
ciably metabolised over the duration of these experiments 
40 
30 
20 
10 
o 
[ 0 
e.. 
100 
~ 8O 
60 
40 
20 
~La 20 40 60 
g-time (7.5+0.6 rain) 
60 120 180 
TIME (rain) 
Fig. 2. Apical-to-basolateral tr nsport kinetics of L-[aH]aspartate. Perme- 
able-support medium was aspirated from the apical (Ap) and basolateral 
(B1) chambers and the monolayers were washed once for 15 min with 2 
ml of transport medium (M4) in each of the apical and basolateral 
compartments (1×(2 ml Ap+2 ml BI)x15 min) before 50 /zM L- 
[3H]aspartate was applied to the apical surface of Caco-2 monolayers. 
Apical-to-basolateral L-[3H]aspartate (50 /xM) transport (O) was deter- 
mined by sequential transfer at 10 min (A) and 30 min (B) intervals. 
Apical-to-basolateral transport of 50 /xM L-[3H]aspartate in the presence 
of a 1000-fold molar excess (50 mM) was also monitored (B; O). Data 
are presented as mean values + S.D. for three monolayers. 
and 3H assays overwhelmingly reflect intact L-[3H]aspar - 
tate. 
L-Aspartate showed rapid apical-to-basolateral t nsport 
across Caco-2 monolayers with an initial lag-time of 7.5 + 
0.6 min followed by a linear phase (transport proportional 
to time; 44.7 _+ 0.6 nmol h -1 insert - l )  which continued 
for at least 60 min (Fig. 2A). Extensive transport was 
observed at low concentrations with 83.8 _+ 1.4% of api- 
cally applied L-aspartate being transported after 180 min. 
The reduction in transport rate at extended time periods 
(i.e., from 90 min; Fig. 2B) reflects this depletion of 
substrate in the apical chamber. The apical-to-basolateral 
transport rate for 50 /xM L-[aH]aspartate was markedly 
reduced ( > 64-fold) by a 1000-fold molar excess (50 mM) 
of unlabelled L-aspartate (Fig. 2 B). Basolateral-to-apical 
L-aspartate transport occurred at a much slower rate and 
was linear over at least 180 min (Fig. 3). 
The initial rate of apical-to-basolateral transport was 
influenced by the age of the monolayer and increased from 
day 7 (23.2 +__ 0.8 nmol h -1 insert -1) to day 14 (38.2 _ 5.0 
nmol h-1 insert-l) of culture; it then remained constant 
through to day 28. In contrast, basolateral-to-apical tr ns- 
port was much slower and changed little over this period 
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Fig. 3. Polarity of L-aspartate transport at 21 d of culture. Caco-2 
monolayers were washed (1X(2 ml Ap+2 ml BI)× 15 rain) with M4- 
medium before 50 ~M L-[3H]aspartate was applied to the apical or 
basolaterai surface of the monolayers, The kinetics of apical-to-baso- 
lateral (0 )  and basolateral-to-apical (©) were monitored by collecting 
the receiver solutions at 30 rain intervals. Data are presented as mean 
values + S.D. for three monolayers. 
(day 7, 4.41 _ 0.13; day 21, 2.87 + 0.06; day 28, 4.15 _ 
0.64 nmol h- l  insert-1). The rate of apical-to-basolateral 
L-aspartate flux (Jtot) was significantly higher (P < 0.001) 
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Fig. 4. Sodium-dependence of apical-to-basolateral L-[aH]aspartate trans- 
port. (A) Caco-2 monolayers were washed (1 ×(2 ml Ap+2 ml BI)x 15 
rain) with M4-medium or M4Ch, as appropriate. Apical-to-basolateral 
transport of L-[3H]aspartate (50 /xM) alone (• ) ,  or in the presence of a 
1000-fold molar excess of L-aspartate (50 mM) of unlabelled L-aspartate 
([]), was determined in the presence and absence of extracellular sodium 
ions. * Denotes a significant reduction in L-[3H]aspartate transport at 
P < 0.001. (]3) Monolayers were washed (1 x(2 ml Ap +2 ml Bi)X 15 
min) with M4-medium containing the appropriate sodium-ion concentra- 
tion. The initial rate of apical-to-basolateral t nsport of L-[3H]aspartate 
(50/xM) was determined in the presence (apical and basolateral) of 0, 10, 
20, 30, 50, 70, 100 and 140 mM sodium ions. Data are presented as mean 
values + S.D. for three monolayers. 
than that in the basolateral-to-apical direction at each 
time-point but the transport was most polar after 21 days 
of culture when apical-to-basolateral transport occurred at 
12.1 + 1.0 times the rate of the reverse process. 
The presence of a 1000-fold molar excess of unlabelled 
L-aspartate (50 mM) drastically reduced, but did not elimi- 
nate, the flux of L-[3H]aspartate (50 /zM), indicating the 
presence of a minor, non-saturable (passive) transport 
component (Jp, 0.884 + 0.053 nmol h -1 insert-l). The 
difference (Jtot- Jp) estimates the saturable (carrier-medi- 
ated) component (J:m) to be 37.7 __+ 01.15 nmol h - l  in- 
sert -1 at 50 /~M (Fig. 4A). In sodium-free conditions 
(M4ch), L-[3H]aspartate (50 /~M) transport was reduced to 
passive-flux rates (Fig. 4A). The saturable transport com- 
ponent was stimulated at low concentrations of extracellu- 
lar sodium ions (Fig. 4B). However, maximal transport 
was only achieved at concentrations approaching physio- 
logical levels (140 mM), although half-maximal stimula- 
tion occurred at ~ 20 mM. Despite an absolute depen- 
dence on extracellular sodium ions, L-aspartate uptake into, 
s A 
OUABAIN CONCENTRATION ~M] 
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Fig. 5. Ouabain-sensitivity and energy dependence of L-aspartate uptake 
and transport. (A) Uptake. Caco-2 monolayers were pre-incubated with 
M4-medium, M4ch (Sodium-free) or M4 containing an appropriate con- 
centration of ouabain. L-[3H]Aspartate (50 mM) uptake over 10 min was 
determined from M4-medium (• ) ,  M4ch (-Na +, [] ) and M4 containing 
10, 50, 100, 1000 or 5000 /xM ouabain (spickled bars). Data are 
presented as mean values + S.D. for three monolayers with * and * * 
denoting significant reductions from control values at P <0.01 and 
P < 0.001, respectively. (B) Transport. Monolayers were pre-incubated 
(2 ml Ap+2 ml BI) for 60 min with M4-medium, M4ch, M4 containing 
50 p,M ouabain or M4 containing sodium azide and 2-deoxyglucose 
(N 3 + 2-DG), as appropriate. The initial rate of apical-to-basolateral L- 
[3H]aspartate ransport was determined from M4 (• ) ,  M4ch (-Na +, D), 
M4 containing 50 /xM ouabain (spickled bar) or M4 containing N~- + 2- 
DG (hatched bar). 
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Table 1 
Cation- and anion-dependence of L-aspartate transport 
Cation Anion L-Aspartate transport 
(% control) [S.D.] 
Na + CI- 100.0 [3.0] §~ 
Na + HOCH2CH2SO ~- 100.3 [1.0] §§ 
Na + NCS- 90.8 [3.2] §§ 
Li + C1- 23.4 [2.2] * § 
K + C1- 14.8 [3.1] * 
Rb + C1- 16.0 [2.4] * 
Cs + C1- 12.3 [1.0] * 
HOCH2CH2 N+ Me 3 C1- 12.5 [0.7] * 
The initial rate of apical-to-basolateral L- spartate (50 /zM) transport was 
determined from M3-medium containing the cation-anion salts shown 
below. Data are presented as mean values + S.D. for three monolayers. 
* Denotes a significant reduction in L-aspartate transport from that in 
sodium chloride; § and §§ denote a significant stimulation of transport 
from that in choline chloride at P < 0.05 and P < 0.001, respectively. 
and transport across, Caco-2 monolayers was diminished 
but not abolished by ouabain. Cellular uptake was reduced 
by 32.3 -t- 1.3% (P < 0.01) by 50 /zM ouabain compared 
with a reduction of 80.6 -t- 3.9% (P < 0.001) from M4ch, 
i.e., on the removal of sodium (Fig. 5A). Similarly, trans- 
port was reduced 16.2___.-4.3% (P<0.05)  by 50 /zM 
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Fig. 6. Concentration-dependence of L-aspartate and L-glutamate trans- 
port. Monolayers were washed (1 x(2 ml Ap+2 ml B1)× 15 min) with 
M4 or M4ch, as appropriate. The initial rate of apical-to-basolateral 
L-aspartate (A) and L-glutamate (B) transport were determined over a 
range of apical concentrations in the presence or absence of extracellular 
sodium ions. The sodium-dependent transport component (---) was esti- 
mated by non-linear egression and calculated for further analysis by 
subtraction of sodium-independent transport (O) from the total transport 
(O). Data are presented as mean values-t-S.D, for three monolayers. The 
kinetic parameters for the saturable transport component for L-aspartate 
(C) and L-glutamate (D) transport were estimated from Eadie-Hofstee 
plots ( jNa= J inx -  KmJ/[S]) of these data; jr~a represents the 
sodium-dependent component of the transport. 
Table 2 
Kinetic parameters for acidic amino-acid transport 
Substrate K m (/~M) Vma x (nmol h-  J insert- I) 
Mean [S.D.] Mean [S.D.] 
L-Aspartate 55.8 [3.3] 230.0 [7.0] 
L-Glutamate 65.0 [6.3] 95.8 [15.3] 
ouabain, but 97.9 +__ 0.7% (P < 0.001) by replacement of
M4 with M4ch (Fig. 5B). The requirement of carrier-medi- 
ated L-aspartate transport for extracellular sodium ions was 
specific. Equimolar eplacement of extracellular Na ÷ with 
K-, Rb ÷ or Cs ÷ failed to stimulate significantly L-aspar- 
tate transport above passive transport-fluxes. Li + produced 
a small, but significant (P < 0.05), stimulation of transport 
compared with choline conditions. The nature of the an- 
ions, in contrast o that of the cations, did not affect 
aspartate transport (Table 1). 
Total transport of acidic amino acids (Jtot) is the sum of 
two terms (Eq. 2), the first being sodium-dependent a d 
the second sodium-independent transport. In the absence of 
sodium ions, transport occurs only by the sodium-indepen- 
dent (diffusional) pathway (Fig. 4, 6). Transport in the 
absence of sodium is linearly dependent upon concentra- 
tion and, hence, is expressible as k[S]. Subtraction of this 
term from -/tot, gives the sodium-dependent components 
( J )  which follows Michaelis-Menten saturation kinetics 
(Fig. 6A and B). Eadie-Hofstee plots of these sodium-de- 
pendent transport components (Fig. 6C and D) were used 
to calculate the Michaelis constant (K m) and maximal flux 
(Jm~x) for both L-aspartate and L-glutamate. Non-linear 
fitting [29] of the transport data to Eq. (2) yielded similar 
results. The kinetic parameters for the sodium-dependent 
L-aspartate and L-glutamate are given in Table 2. 
Jmax[ S]  
Jtot = Km + I s ]  + k [S]  (2 )  
The rate of apical-to-basolateral L-aspartate transport 
against a 10-fold reverse concentration-gradient was indis- 
tinguishable from that in the absence of a gradient (Table 
3). L-Aspartate transport was significantly (P < 0.05) re- 
duced (from 34.0 _ 1.34 to 23.8 ± 0.77 nmol h -1 insert- l) 
Table 3 
L-Aspartate transport against a 10-fold concentration-gradient 
Time (min) Transport (nmol) [S.D.] 
30 60 90 120 150 
Control 14.6 [0.4] 38.0 [0.7] 55.2 [1.5] 69.3 [0.8] 77.3 [0.8] 
Gradient 13.4 [0.16] 35,7 [1.2] 53.4 [2.0] 66.5 [1.6] 74.3 [1.9] 
Monolayers were washed (1×(2 ml Ap+2 ml B1)X15 min) with 
M4-medium before 50 /xM L-[3H]aspartate was applied to the apical 
chamber. In the control group the receiver-solution comprised M4-medium 
alone and in the test group the receiver-solution comprised M4-medium 
supplemented with 500/zM unlabelled L-aspartate. Data are presented as 
mean values + S.D. for three monolayers 
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Fig. 7. pH-dependence of L-aspartate transport. Caco-2 monolayers were 
washed (1 X 2 ml Ap X 15 min) with M4-medium buffered to an appropri- 
ate pH (5.5, 6.0, 6.5, 7.0, 7.5, 8.0) and (1X(2 ml B1)×15 min) with 
M4-medium pH 7.4. The initial rate of apical-to-basolateral 50 /xM 
L-aspartate transport was determined for a range of apical pH values (pH 
5.5 to 8.0). Data are presented as the mean + S.D. for three monolayers. 
* Denotes a significant reduction from L-aspartate transport at pH 6.5. 
by a 45 min pre-incubation with 500 txM cycloheximide. 
In addition, there was a bell-shaped pH-dependence with a 
broad pH-optimum between pH 6.5 (31.2 _ 1.3 nmol h- 
insert- ~) and 7.5 (30.6 __ 2.1 nmol h- 1 insert- l) and 
transport was significantly reduced outside this range (Fig. 
7) although the passive permeability of the monolayer over 
this pH range was unaffected. Finally, L-aspartate ransport 
was significantly reduced at temperatures below 37°C, 
from 38.0 + 1.3 to 12.3 + 0.5 (67.6 _ 1.1%) and 0.66 + 
0.03 (99,0___ 0.1%) nmol h -l insert-l at 20 and 4°C, 
respectively (P  < 0.001). The available data followed the 
Arrhenius equation closely and logarithmic transformation 
yielded an activation energy (E a) for L-aspartate transport 
across Caco-2 monolayers of 101.6 + 1.0 kJ mol -l by 
linear least-squares regression. 
Cross-inhibition transport studies between radiolabelled 
L-aspartate (1) or L-glutamate (6) at 50 /xM and a 20-fold 
molar excess (1 mM) of a series of unlabelled competitors 
showed the acidic amino-acid carder to have stringent 
structural-requirements for competing ligands (Table 4). 
The L -- and D-isomers of aspartate were equally effective 
and potent inhibitors (92.l + 3.5% and 88.01 + 1.7%, re- 
spectively; P < 0.001) of L-aspartate transport. Interest- 
ingly, L-glutamate was a strong inhibitor (74.8_ 0.7%; 
P < 0.001) whilst its enantiomer o-glutamate was only a 
weak inhibitor (23.5 + 8.8%; P < 0.05) of transport. Simi- 
larly, L-aspartate, D-aspartate and L-glutamate are potent 
inhibitors of L-glutamate transport whilst D-glutamate was 
a weak inhibitor. The small neutral amino acids (L-alanine, 
L-asparagine and L-proline) were weak inhibitors whilst 
larger neutral amino acids (L-methionine and L-phenyl- 
alanine) failed to inhibit L-aspartate transport significantly. 
The organic anions, 4,4'-diisothiocyanatostilbene-2,2'-dis- 
Table 4 
Inhibition of acidic amino-acid transport by various competitors 
Type Competitor Inhibition (%) Mean [S.D.] 
L-Aspartate L-Glutamate 
Natural amino acids 
Stereoisomers 
Organic anions 
Synthetic analogues 
L-Aspartate (1) 92.1 [2.0] * * 73.9 [14.8] * * 
L-Glutamate (6)  74.8 [0.4] " ' 70.1 [3.8] " * 
L-Asparagine 26.2 [5.5] * - 
L-Proline 22.0 [3.1] * - 
L-Alanine 17.2 [ 1.7] * - 
L-Cysteine 14.5 [3.0] - 
L-Histidine 12.8 [1.7] - 
L-Phenylalanine 8.1 [1.4] - 
L-Methionine 6.3 [4.5] - 
L-Serine -- 0.2 [5.3] - 
Glycine - 6.6 [4. l ] - 
o-Aspartate 88.0 [ 1.0] * * 85.5 [ 1.9] " * 
D-Glutamate 23.5 [5.1 ] * 24.5 [6.1 ] * 
4-Aminohippurate 13.6 [6.4] - 
4,4'-Diisothiocyanatostilbene-2,2'-disulfonate 6.5 [1.6] - 
Succinate 2.8 [2.4] - 
Threo-fl-hydroxy-DL-aspartate 90.7 [0.6] * * - 
OL-3-(Hydroxyphosphoryl)alanine (2)  89.8 [0.5] * * 88.0 [0.3] * * 
L-Cysteic acid (4) 89.2 [0.7] * * 89.0 [0.5] * * 
ot-Methyl-oL-aspartate 40.0 [1.4] * - 
DL-3-Arsonoalanine (5)  32.5 [1.7] * 44.2 [7.6] * 
DL-3-Phosphonoalanine (3) 13.9 [2.7] - 
N-Methyl-l~-aspartate 14.5 [4.1] - 
OL-2-Amino-4-arsonobutyric acid (8)  2.7 [1.5] - 
DL-2-Amino-5-phosphonopentanoic acid 1.5 [6.6] - 
OL-2-Amino-4-phosphonobutyric ac d (7)  -2 .5  [0.6] - 
Monolayers were washed (1 X (2 ml Ap + 2 ml BI) X 15 min) with M4-medium. They were incubated with 50 /~M acidic amino acid alone or in the 
presence of 1 mM of competitor. Data are presented as mean percentage inhibition 5: S.D. for three monolayer with " and * * denoting significant 
inhibition at P < 0.01 and P < 0.001, respectively 
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Table 5 
Estimated K i values for a range of competitors of L-aspartate ransport 
Competitor K i (/xM) 
Threo-fl-hydroxy-DL-aspartate 55 
DL-3-(Hydroxyphosphoryl)alanine (2) 60 
L-Cysteic acid (4) 65 
D-Aspartate 70 
L-Glutamate (6) 180 
o~-Methyl-DL-aspartate 790 
DL-3-Arsonoalanine (5) 1100 
L-Asparagine 1550 
D-Glutamate 1720 
L-Proline 1870 
L-Alanine 2540 
N-Methyl-DL-aspartate 3120 
DL-3-Phosphonoalanine (3) 3270 
ulfonate, 4-aminohippurate and succinate did not signifi- 
cantly reduce L-aspartate transport. 
Synthetic analogues howed a differential ability to 
inhibit L-aspartate and L-glutamate transport (Table 5). 
Potent inhibition of acidic., amino-acid transport was re- 
tained after minor structural modifications of L-aspartate 
and L-glutamate. For example, insertion of a hydroxyl 
group in the threo-configuration at the r-position of the 
L-aspartate side-chain did not impair inhibition (threo-fl- 
hydroxy-DL-aspartate, 90.7 _ 0.6%; P < 0.001). In addi- 
tion, some modifications to the side-chain carboxylate 
function preserved the inhibitory properties. For example, 
L-cysteate (4) and DL-3-(hydroxyphosphoryl)alanine (2) 
were strong inhibitors of acidic amino-acid transport. The 
arsono analogue of L-aspartate (DL-3-arsonoalanine, 5)
inhibited L-aspartate (32.5 + 1.7%; P<0.01)  and L- 
glutamate (44.2 + 7.6%; p < 0.01) transport more weakly. 
However, the arsono analogue of glutamate (DL-2-amino- 
4-arsonobutyric a id, 8) failed to significantly inhibit L- 
aspar ta te  t ranspor t .  Wh i l s t  DL -3 -  
(hydroxyphosphoryl)alanine (2; 89.8 _ 0.5%; P < 0.001) 
is a potent inhibitor of L-aspartate transport, he phosphono 
analogue of aspartate (DL-3-phosphonoalanine, 3; 13.9 + 
2.7%) did not inhibit transport. The phosphono analogue 
of glutamate (7) failed to inhibit acidic amino-acid trans- 
port significantly. 
4. Discussion 
Mechanistic studies of the intestinal uptake and trans- 
port of acidic amino acids are hampered by their instability 
towards metabolic enzymes [30]. In contrast, no significant 
degradation was observed during experiments with the 
Caco-2 monolayers with radioactivity remaining associated 
with the substrate for the duration of the experiment. This 
surprising stability may be due to a low intrinsic metabolic 
activity within Caco-2 cells but, also, it may reflect the 
reduced opportunity for metabolism as the amino acid 
crosses the Caco-2 monolayer compared to the diverse, 
multi-cellular barriers which must be navigated in whole 
tissue. Both aspartate and glutamate were readily trans- 
ported across the monolayer, predominantly b  a transcel- 
lular, carrier-mediated (> 95%) pathway. This conclusion 
is supported by the fact that a 10-fold reverse concentra- 
tion-gradient had no effect on the rate of apical-to-baso- 
lateral transport; an observation that contrasts with whole 
tissue preparations, which failed to show transport against 
a concentration-gradient. Further, L-aspartate and L- 
glutamate transport were concentration-dependent with an 
absolute sodium-dependence being demonstrable for the 
saturable component (Fig. 4); the stoichiometric analysis 
of this interaction suggested that up to two sodium ions 
could be involved with each amino acid. Moreover, L- 
aspartate transport had a skewed bell-shaped pH-depen- 
dence (Fig. 7). This did not reflect the pH-effects on the 
passive permeability of Caco-2 monolayers nor did it 
follow the ionisation profile of L-aspartate (pK a 2.0, 3.9, 
10.0) and probably corresponds to changes in the ionic 
state of a transporter. In addition, L-aspartate was also 
transported in a vectorial manner while the activation 
energy (E a) for L-aspartate transport across Caco-2 mono- 
layers (101.6 ___ 1.0 kJ mo1-1 ) greatly exceeded that antici- 
pated for simple diffusion (< 16.8 kJ mo1-1) and is within 
the usual range for carrier-mediated transport processes 
(29.4 to 105.0 kJ mo1-1) [9]. Finally, cross-inhibition 
studies have shown that L-aspartate and L-glutamate trans- 
port can be inhibited by a narrow range of closely related 
structural analogues (Table 4). The substrate specificity 
was consistent with the transport pathway being of XAC 
type, since it was sodium-dependent a d served L-aspar- 
tate, D-aspartate and L-glutamate but not D-glutamate. 
The saturable component of the transport of acidic 
amino acids across Caco-2 monolayers required sodium 
ions, so that the in their absence the total fluxes of 
L-aspartate and L-glutamate were reduced to the rate of 
passive diffusion, which was proportional to substrate 
concentration (Fig. 4). This parallels observation i LLC- 
PK~ cells [31], cells isolated from chicken small intestine 
[32] and BBM V prepared from human [4,5], rabbit [33] 
and rat [34]. A half-maximal stimulation of L-aspartate 
transport across Caco-2 monolayers occurred at low extra- 
cellular sodium-ion concentrations (= 20 mM) and maxi- 
mal stimulation occurred at [Na +] > 100 mM. Moreover, 
the transport of L-aspartate across Caco-2 monolayers i  
cation-specific (Table 1). In the presence of extracellular 
sodium chloride (140 mM), the rate of L-aspartate ransport 
exceeded by six-fold that in the presence of an equal 
concentration of K ÷, Rb ÷, Cs ÷ or choline. A small but 
significant stimulation of transport by Li ÷, above the 
choline control, suggests this cation can partially substitute 
for Na +. These observations support hose in rat intestinal 
BBMV [34] although partial stimulation by Li ÷ was not 
observed there. Transport of L-aspartate was reduced to 
83.8 + 1.9% of its control value in the presence of the 
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ouabain, a Na+/K + ATPase inhibitor. This contrasts with 
the much larger reduction (to 17.4 + 2.8%) observed with 
L-proline [13]. In the latter case, higher extracellular Na ÷ 
concentrations are required (half-maximal = 50 mM; max- 
imal > 140 mM), perhaps indicating that an inward 
sodium-gradient may be required, a factor that may con- 
tribute to the greater ouabain-sensitivity of L-proline up- 
take by Caco-2 monolayers compared to that of L-aspar- 
tate. Here, it is possible that the results may reflect a 
movement of L-aspartate down a concentration-gradient 
using available sodium ions in the absence of a sodium 
gradient. To investigate any direct anion-dependence or the 
possibility of an electrogenic transport, L-aspartate trans- 
port experiments were performed using incubation medium 
containing the sodium salts of anions having a range of 
permeabilities (thiocyanate > chloride > isethionate). For 
example, glucose uptake into human jejunal BBMV is 
electrogenic and is increased by replacing chloride anions 
in the incubation medium with the more lipophilic thio- 
cyanate [4]. In the same study, L-glutamate uptake into 
human jejunal BBMV was not anion-sensitive. Similarly, 
L-aspartate transport across Caco-2 monolayers i anion-in- 
sensitive. This is consistent with an electroneutral process 
but contrasts with rat BBMV where L-aspartate and L- 
glutamate uptake were reduced (> 60%) by equimolar 
substitution of chloride with thiocyanate [35]. 
Transport of L-aspartate and L-glutamate across Caco-2 
cells followed the proposed model (Eq. 2) closely; the 
sodium-dependent component was explained by the 
Michaelis-Menten relationship suggesting that, at pH 7.4, 
transport is controlled by a single high-affinity carrier. In 
parallel with this finding, a single high affinity (K m 30 
/zM), sodium-dependent up ake system is expressed in the 
LLC-PK l cell line; in BBMW prepared from the rat 
intestine, Corcelli and co-workers [33] have reported a 
single sodium-dependent carrier (K m 1.0 mM and 1.5 mM 
for L-aspartate and L-glutamate, respectively); and a single 
high-af f in i ty  (K  m = 91 /zM) carrier has been reported in 
human jejunal BBMV [4]. In contrast, although a single 
high-af f in i ty  (K  m 4 -8  /~M) sodium-dependent L-gluta- 
mate uptake in isolated segments of chick intestine has 
been described [36], both high- (K m 16 /xM) and low- 
(K m 2.7 mM) affinity sodium-dependent up ake pathways 
for L-aspartate in the same species have been reported [32]. 
The Michaelis constant for L-glutamate transport across 
Caco-2 monolayers was 65.0 -4- 6.3 /xM which is compara- 
ble to that for uptake into human jejunal BBMV. L-Aspar- 
tate had a higher affinity (K  m = 55 .8 - t -3 .3  /zM); this is 
reflected in the cross-inhibition studies in which a 20-fold 
molar excess of unlabelled L-aspartate inhibited 50 ~M 
L-[3H]aspartate transport by 92.1 __+2.0%, whereas L- 
glutamate resulted in only a 74.8 ___ 0.4% inhibition. Al- 
though consistent, his analysis probably oversimplifies the 
mechanisms involved. In particular, in BBMV from rabbit 
renal cortex, the electrogenicity of the transport varies with 
experimental conditions; an observation which was ex- 
plained in terms of a potential-dependent, substrate-trans- 
locating forward process and an electroneutral return com- 
ponent [37]. 
The pH-profile for the apical-to-basolateral t nsport of 
L-aspartate across Caco-2 monolayers has a skewed bell- 
shape (maximum = pH 6.5) (Fig. 7). This pH-dependence 
is similar to that for L-glutamate uptake into human jejunal 
BBMV [4] and provides support for the conclusion that 
Caco-2 monolayers are a suitable tool for studying the 
human XAG transporter. Analogous pH-dependence has 
been noted for the uptake of L-glutamate into both human 
[5] and rabbit [33] jejunal BBMV. Optimum pH conditions 
were slightly acidic (pH 6.5) and non-acidic (pH 7.0 to 
7.5) for the human and rabbit BBMV, respectively. In the 
rabbit jejunal BBMV model, it has been reported [38] that 
at pH 8.0 both D-aspartate and L-glutamate are served by a 
single high-affinity system (g  m = 30 // .M) while, under 
acidic conditions (pH 6.0), D-aspartate was transported by 
the high-affinity system alone, whereas L-glutamate trans- 
port was mediated by both a high and low (K m = 25 mM) 
transporters. This dependence upon pH was accompanied 
by a change in the cross-inhibition profile but the effect 
has yet to be confirmed in other species and models. 
To probe the structural requirements of the Caco-2 
carrier of acidic amino acids, the transport of radiolabelled 
L-aspartate and L-glutamate was assessed in the presence 
of a 20-fold molar excess of various competitors (Table 4 
and 5). A high specificity was observed. The lack of 
interaction with acids (4,4'-diisothiocyanatostilbene-2,2'- 
disulfonate and p-aminohippurate) precluded transport via 
a general organic anion-transporter while the failure of 
succinate (-O2C-CH2-CH2-CO~-) to inhibit L-aspartate 
transport suggests that an amino group is required for 
recognition. L-Alanine, L-asparagine and L-proline were 
weak inhibitors of L-aspartate transport across Caco-2 
monolayers. Partial inhibition of acidic amino-acid trans- 
port by L-alanine, L-leucine and L-proline has been re- 
ported in chick intestinal cells [32]. Such compounds are 
not substrates for the XAC transporter [13] but may be able 
to bind reversibly without activating the transport. Some 
structural modifications maintain a high degree of interac- 
tion with the transporter. For example, threo-fl-hydroxy- 
DL-aspartate retains almost complete ability to inhibit L- 
aspartate transport (K~ 55/zM). In contrast, methylation of 
the a-carbon (c~-methyl-DL-aspartate) reduced the interac- 
tion (K i 790 /zM), while N-methylation (N-methyl-DL- 
aspartate) virtually abolished inhibition (K  i 3120 /xM). 
The transporter clearly has well-defined steric require- 
ments. Substitution of the /3-carboxylate group for the 
mono-anionic sulfo (4) or hydroxyphosphoryl (-
(H)P(O)O-, 2) residues also maintained inhibition po- 
tency. This suggests that the recognition site for the /3- 
carbon anionic centre has some steric tolerance, since it 
accepts both the tetrahedral sulfonate and phosphinate 
groups in addition to the natural planar carboxylate. The 
K i values for threo-/3-hydroxy-DL-aspartate (55 /xM), L- 
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cyste ic  ac id (4 ,  65 /xM)  and DL-3- 
(hydroxyphosphoryl)alanine (2, 60 /zM) were comparable 
to the K m values for L-aspartate transport (55.8 ~M), 
indicating that they approach the affinity of the natural 
ligand for the transporter (Table 4). In contrast, a similar 
substitution with phosphono (DL-3-phosphonoalanine, 3) 
severely reduced inhibition (K  i 3270 /xM). Such a differ- 
ence has been reported previously for substrates of D-3-hy- 
droxybutyrate d hydrogenase [39] where 3-oxobutyrate and 
3-oxopropanesulfonate where reduced by the enzyme, 
whereas a phosphonate analogue was not. The ability of 
both the planar -CO0- and tetrahedral -SO 3 to interact 
with the enzyme was explained in terms of their rotational 
symmetry which enables effective alignment of dipoles. A 
phosphonate group, to interact at such an active site, 
requires to be in the monoionic state [21], this species is 
not symmetrical nd binding is poor because of distorted 
interactions. Such alignment may not be needed for bind- 
ing to the transporter, atleast if the group is not too bulky, 
since the hydroxyphosphorylalanine (2) is a good in- 
hibitor. 
Surprisingly, the arsono analogue (5) was a more effec- 
tive inhibitor (K i 1100/zM); this effect may be related to 
the ionic state of the substrate. Typically, the p K a values 
of the phosphono group are ~ 2.2 and ~ 7.2. Since 
transport experiments were performed at pH 7.4, approx. 
60% of DL-3-phosphonoalanine (3) exists as the di-anionic 
form. In contrast, the p K a values of a typical arsonic acid 
are, typically, 3.5 and 8.5. The difference in ionisation 
between 3 and 5 (2.3-fold more mono-anion in 5) paral- 
lels the increase in K i (3-fold) and supports the above 
argument which suggests that a mono-anionic side-chain is 
optimum. Extension of the: methylene chain in these ana- 
logues (7,8) largely eliminated interaction with the trans- 
porter although the arsono compound was still more effec- 
tive. DL-3-(hydroxyphosphoryl)alanine (2) and DL-3- 
arsonoalanine (5) are novel inhibitors of acidic amino-acid 
transporters. 
Inhibition of XA6 carriers in human [4], rabbit [38] and 
rat [34] intestinal BBMV, LLC-PK 1 [31] and H35 
(hepatoma) [40] cell lines, cultured rat hepatocyte and skin 
fibroblasts [41] has been reported previously. The uptake 
of radiolabelled cysteate was strongly inhibited by L- 
aspartate, L-glutamate, D-aspartate and 3-aminoglutarate 
but not D-glutamate [41]. Inhibition by 3-aminoglutarate 
indicates that the amino group does not have to be at the 
a-position for recognition. Christensen and colleagues 
[40,41] suggested that this anomalous tereo-selectivity s 
due a reversal in the binding of D-aspartate compared to 
the L-stereoisomer. Thus, the a- and/3-carboxylate groups 
of aspartate bind in a, /3 (L-aspartate) and /3, a (D-aspar- 
tate) orientations while the a- and y-carboxylate groups of 
glutamate bind in a, Y (L-glutamate) but not in T, a 
(D-glutamate) orientations. A refinement is shown 
schematically in Fig. 8 where it is proposed that the acidic 
amino-acid carrier has fi3ur recognition domains, two 
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Fig. 8. Proposed recognition of acidic amino acids by the XAG carrier. A, 
L-aspartate; B, D-aspartate; C, L-glutamate; D, D-glutamate; E, 3-aminog- 
lutarate; F, raeso-2,3-diaminosuccinic acid. Shaded encircled regions 
indicate that the receptor surface is above the plane of the molecule and 
unshaded encircled regions indicate that it is below this plane; the circles 
drawn around these sites are continuous ( - - )  for positively charged sites 
on the receptor and dashed (---) for negatively charged sites. 
cationic and two anionic centres. For substrate recognition, 
at least three of the four domains need to be associated 
with ligands. This model accounts for the recognition of 
L-aspartate (Fig. 8A), n-aspartate (Fig. 8B), L-glutamate 
and 3-aminoglutarate; he more eclipsed contribution to the 
conformation in the latter pair (Fig. 8C, 8E) perhaps 
contributes to their poorer interaction. D-Glutamate (Fig. 
8D) may also interact similarly in the reverse orientation; 
this is not observed, perhaps indicating stricter steric de- 
mands in this orientation. The model predicts that di- 
aminosuccinic acid would be a potent inhibitor of acidic 
am ino -ac id  t ranspor t  w i th  m eso-  
HOOC(NH2)CHCH(NHz)COOH (Fig. 8F) being optimal. 
This suggestion awaits experimental verification. 
5. Conclusion 
A transporter, probably an XAC type, which is distinct 
from other amino-acid carders characterised in the Caco-2 
cell line, is implicated in L-aspartate and L-glutamate trans- 
port. The g m values for L-aspartate (55.8 _ 3.3 ~M) and 
L-glutamate (65.0 _ 6.3 /zM) using this system are 5-fold 
lower than that for L-glutamine (276 /zM) [42], one order 
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of magnitude lower than for L-phenylalanine (560 /zM, via 
LNAA transporter) [9] and two orders of magnitude lower 
than the uptake for L-proline via A-system (5480 /xM,) 
[13]. Additionally, the acidic amino-acid transporter has a 
different cross-inhibition profile from the LNAA and A- 
system pathways and is inhibited strongly only by close 
analogues of the natural substrates. Small neutral amino 
(and imino) acids weakly inhibit transport but large neutral 
amino acids have little effect; L-aspartate failed to interfere 
with L-proline uptake [13] or L-phenylalanine transport [9] 
across Caco-2 monolayers.Moreover, whilst acidic amino- 
acid transport has an absolute sodium-dependence, L- 
phenylalanine is at best only partially ( = 33%) sodium-de- 
pendent [9]. The results described here correlate well with 
human intestinal uptake of acidic amino acids and suggest 
that Caco-2 monolayers represent a useful experimental 
tool for studying the transport of acidic amino acids and 
analogues across the human GI epithelium. 
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